These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34396271)

  • 1. Immune Checkpoint Inhibitor Therapy Aggravates T Cell-Driven Plaque Inflammation in Atherosclerosis.
    Poels K; van Leent MMT; Boutros C; Tissot H; Roy S; Meerwaldt AE; Toner YCA; Reiche ME; Kusters PJH; Malinova T; Huveneers S; Kaufman AE; Mani V; Fayad ZA; de Winther MPJ; Marabelle A; Mulder WJM; Robert C; Seijkens TTP; Lutgens E
    JACC CardioOncol; 2020 Nov; 2(4):599-610. PubMed ID: 34396271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice.
    Poels K; van Leent MMT; Reiche ME; Kusters PJH; Huveneers S; de Winther MPJ; Mulder WJM; Lutgens E; Seijkens TTP
    Cells; 2020 Aug; 9(9):. PubMed ID: 32872393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT.
    Dimitrakopoulou-Strauss A
    Cancer Immunol Immunother; 2019 May; 68(5):813-822. PubMed ID: 30123922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[
    Calabretta R; Beer L; Prosch H; Kifjak D; Zisser L; Binder P; Grünert S; Langsteger W; Li X; Hacker M
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38276275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the role of colonic and other anatomical sites uptake by [
    Rizzo A; Cantale O; Mogavero A; Garetto L; Racca M; Venesio T; Anpalakhan S; Novello S; Gregorc V; Banna GL
    Thorac Cancer; 2023 Aug; 14(24):2473-2483. PubMed ID: 37442801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.
    Seban RD; Moya-Plana A; Antonios L; Yeh R; Marabelle A; Deutsch E; Schwartz LH; Gómez RGH; Saenger Y; Robert C; Ammari S; Dercle L
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2301-2312. PubMed ID: 32206839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade.
    Tsai KK; Pampaloni MH; Hope C; Algazi AP; Ljung BM; Pincus L; Daud AI
    J Immunother Cancer; 2016; 4():58. PubMed ID: 27660712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibition alters the inflammatory cell composition of human coronary artery atherosclerosis.
    Newman JL; Stone JR
    Cardiovasc Pathol; 2019; 43():107148. PubMed ID: 31518915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
    Jang SR; Nikita N; Banks J; Keith SW; Johnson JM; Wilson M; Lu-Yao G
    JAMA Netw Open; 2021 Dec; 4(12):e2136823. PubMed ID: 34854905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report.
    Tominaga K; Takeuchi K; Takakuma S; Sakamoto E; Hatanaka S; Kajimoto Y; Toda E; Terasaki Y; Kunugi S; Terasaki M; Shimizu A
    BMC Nephrol; 2023 Mar; 24(1):48. PubMed ID: 36894873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry.
    Sun MM; Kelly SP; Mylavarapu Bs AL; Holland GN; Coleman AL; Yu F; Hsu Ms S; Lum F; Gordon LK
    Ophthalmology; 2021 Jun; 128(6):910-919. PubMed ID: 33166553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice.
    Mulholland M; Kritikou E; Katra P; Nilsson J; Björkbacka H; Lichtman AH; Rodriguez A; Engelbertsen D
    JACC CardioOncol; 2022 Dec; 4(5):635-645. PubMed ID: 36636446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
    Bala G; Blykers A; Xavier C; Descamps B; Broisat A; Ghezzi C; Fagret D; Van Camp G; Caveliers V; Vanhove C; Lahoutte T; Droogmans S; Cosyns B; Devoogdt N; Hernot S
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):1001-8. PubMed ID: 26800768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
    Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
    Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of 2-[
    Manson G; Lemchukwu AC; Mokrane FZ; Lopci E; Aide N; Vercellino L; Houot R; Dercle L
    Eur Radiol; 2022 Sep; 32(9):6536-6544. PubMed ID: 35344061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.